首页> 外国专利> Induction of REV and TAT-specific cytotoxic T-cells for prevention and treatment of human immunosuppressive virus (HIV) infection

Induction of REV and TAT-specific cytotoxic T-cells for prevention and treatment of human immunosuppressive virus (HIV) infection

机译:诱导REV和TAT特异性细胞毒性T细胞预防和治疗人类免疫抑制病毒(HIV)感染

摘要

The presence of cytotoxic T-cells to the Rev and/or Tat protein in samples from a subject infected with immunodeficiency virus, particularly HIV in humans, is an indication of a stable disease condition and a favorable prognosis of lack of progression to disease. Immunogenic compositions containing at least one cytotoxic T-cell epitope of the Rev and/or Tat protein of an immunodeficiency virus, particularly HIV, or a vector encoding the T-cell epitope, may be used to prevent infection by disease caused by the immunodeficiency virus, by stimulating, in the host, a specific cytotoxic T-cell response specific for the respective Rev and/or Tat proteins.
机译:在感染了免疫缺陷病毒,尤其是人类HIV的受试者的样品中,存在针对Rev和/或Tat蛋白的细胞毒性T细胞,这表明疾病状况稳定,并且预后良好,无疾病进展。包含免疫缺陷病毒,特别是HIV的Rev和/或Tat蛋白的至少一种细胞毒性T细胞表位的免疫原性组合物,或编码该T细胞表位的载体,可以用于预防由免疫缺陷病毒引起的疾病的感染。通过刺激宿主中对各自的Rev和/或Tat蛋白具有特异性的特异性细胞毒性T细胞应答。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号